Benefits
Increased muscle protein synthesis in older adults
A 15 g leucine-enriched whey beverage (PepForm-formulated) containing 4.2 g total leucine produced significantly greater rates of muscle protein synthesis vs an iso-nitrogenous control beverage containing 1.3 g leucine in healthy older women. Leucine content is a determinant of MPS response in this population where age-related anabolic resistance limits standard protein effectiveness.
Higher MPS than control whey blends
In healthy older adults, 20 g whey protein plus 3 g total leucine produced muscle fractional synthesis rate (FSR) of 0.078%/h vs 0.057%/h for iso-caloric milk protein control. The effect occurred after unilateral resistance exercise, demonstrating practical relevance for exercise-recovery applications.
40% leucine content (4× standard whey)
PepForm Leucine Peptides deliver 40% leucine content — substantially higher than whole whey protein (~10% leucine). Practical advantage: small added doses to existing protein products can boost leucine to the 2.5-3 g/serving threshold for maximal MPS stimulation, without requiring large protein volumes.
Soluble and bioavailable form
Free leucine has poor solubility and gritty mouthfeel — limiting use in ready-to-drink products. PepForm's peptide-bound delivery substantially improves solubility, dissolution, and palatability. Suitable for clear beverages, shots, and other applications where free leucine is impractical.
mTOR pathway activation
Leucine is the primary amino acid trigger for mTORC1 (mechanistic target of rapamycin complex 1) — the master regulator of muscle protein synthesis. Adequate leucine (2.5-3 g/dose) maximally activates this pathway; lower amounts produce sub-maximal MPS responses. PepForm enables reliable mTOR activation at lower total protein doses than whole whey.
Sarcopenia and elderly muscle support
Most relevant application: older adults with anabolic resistance to standard protein doses. Leucine threshold rises with age — older adults need higher leucine per meal to achieve the same MPS response as younger adults. Leucine-enriched protein products like PepForm address this physiological shift directly.
Mechanism of action
mTORC1 pathway activation
Leucine activates mTORC1 via Sestrin2-Rag GTPase signaling. mTORC1 phosphorylates downstream effectors (S6K1, 4E-BP1) that initiate ribosomal protein synthesis. The leucine threshold for maximal mTORC1 activation is approximately 2.5-3 g per meal in younger adults; higher in older adults.
Peptide carrier delivery
Glanbia's PepForm technology binds free leucine to peptides via proprietary processing, improving solubility, taste profile, and possibly absorption kinetics. The peptide carrier delivers the amino acid in a form chemistry more similar to physiological dietary protein digestion products.
Insulinogenic effect
Leucine is mildly insulinogenic, stimulating insulin secretion independently of glucose. The mild insulin rise supports anabolic signaling and amino acid uptake into muscle tissue — complementing the direct mTOR-stimulating effect of leucine.
Anabolic resistance compensation in older adults
Older adults exhibit 'anabolic resistance' — diminished MPS response to standard protein doses. Mechanism includes reduced muscle insulin sensitivity, diminished amino acid sensing, and altered mTOR signaling. Leucine enrichment compensates by providing supramaximal leucine signal to overcome the resistance threshold.
Clinical trials
Single-blind randomized parallel-group trial in healthy older women.
Clinical population described in trial publication.
Single-blind randomized parallel-group trial in healthy older women. Intervention: 15 g milk protein + 4.2 g total leucine (PepForm-formulated) vs 15 g blended protein control with 1.3 g leucine, both at rest and following resistance exercise. Outcome: significantly greater rates of muscle protein synthesis (acute and longer-term) in the leucine-enriched group. Establishes leucine content as a primary determinant of MPS response in older populations.
Randomized double-blind trial in healthy older adults.
Older adults
Randomized double-blind trial in healthy older adults. Intervention: 20 g whey protein + 3 g total leucine vs 6 g milk protein control, immediately after unilateral resistance exercise. Postprandial mixed muscle FSR measured over 4 hours via tracer infusion. Outcome: FSR significantly higher with leucine-enriched whey (0.078%/h) vs control (0.057%/h, P=0.049). Higher postprandial EAA and leucine concentrations mediated the FSR response.